Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

4(50.0%)

Phase 1

2(25.0%)

N/A

1(12.5%)

Phase 2

1(12.5%)

8Total

Phase 4(4)

Phase 1(2)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06488794Phase 2Not Yet Recruiting

Nebulised Colistimethate Sodium to Prevent Pediatric Ventilator-associated Pneumonia

Role: lead

NCT05953571Completed

Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics

Role: collaborator

NCT05871073Phase 4Completed

Dexamethasone as Adjuvant to Ropivacaine in Wound Infiltration for Postoperative Analgesia Following Spinal Surgery

Role: lead

NCT05314673Phase 4Completed

Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients

Role: lead

NCT04552067Phase 1Completed

Enoxaparin Bioequivalence Study in Acute Coronary Syndrome Patients

Role: collaborator

NCT02152423Phase 1Completed

Enoxamed Study in the Treatment of Acute Coronary Syndromes

Role: collaborator

NCT03851692Not ApplicableCompleted

Intravenous Cannulation In Children During Sevoflurane Induction

Role: lead

NCT01687491Phase 4Completed

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

Role: collaborator

NCT01509365Phase 4Completed

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27

Role: collaborator

All 9 trials loaded